Welcome to YLOAN.COM
yloan.com » Medical » Why Is Capa So Often Cited In Medical Device Inspections - Webinar By Globalcompliancepanel
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Why Is Capa So Often Cited In Medical Device Inspections - Webinar By Globalcompliancepanel

Overview: This presentation will explore FDA Corrective Action and Preventive Action

findings in medical device manufacturer quality systems to determine FDA's concerns.

The FDA and ISO 13485 requirements for CAPA will be reviewed to identify how procedures may define a compliant CAPA system. Implementation and maintenance of the CAPA system will be explored. FDA indicates that CAPA systems should be risk-based. The presentation will give an example of how to develop a risk-based CAPA system.

Why should you attend: In reviewing FDA Form 483 inspection observation reports and Warning Letters which are published on FDA website, we find CAPA cited in most cases. CAPA has been part of FDA regulations on the medical device industry since the 1970's and companies should have developed good CAPA systems some years ago. But FDA continues to find problems with Corrective Action and Preventive Action in quality systems. This is a foundation of the quality system and should be a well-controlled process. FDA feels CAPA is a very important process so it is always inspected as a part of routine inspections, and it usually one of the first quality management subsystems to be reviewed by investigators.

Areas Covered in the Session:

* Review CAPA citations in FDA-483 and Warning Letters

* Identify common problems with CAPA

* Identify FDA CAPA regulatory requirements

* Identify ISO 13485 CAPA requirements

* Explore FDA's risk expectations of CAPA systems

* Establishing a risk-based CAPA system

Who Will Benefit:

* Regulatory Management

* Internal Auditors

* Quality System Managers

* Quality Engineers

* Regulatory Associates

by: GlobalCompliancePanel
New Drug for Medical Treatment of Androgenetic Alopecia or Male Pattern Hair Loss Drive medical – Designs and manufactures reliable and dependable mobility aids What To Do In A Medical Emergency Telemedicine For The Elderly Telemedicine, Positive And Negative Aspects How to Treatment Dual Addictions at a Private Drug Treatment Center Drugs' Effects on Dopamine When to Make a Long-Term Committment at a Private Drug Treatment Center Medical Bills In Your Credit History; Why Your Medical Credit Score is So Important How To Become A Medical Billing And Coding Specialist How Relapse Prevention is Implemented in Private Drug Treatment Centers A Deeper Look at Private Drug Treatment Centers Performance enhancing drugs
print
www.yloan.com guest:  register | login | search IP(13.59.198.133) Washington / Seattle Processed in 0.008509 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 32 , 1812, 92,
Why Is Capa So Often Cited In Medical Device Inspections - Webinar By Globalcompliancepanel Seattle